* In a 17 to four to one vote, an FDA panel is recommending the agency give emergency approval to the first coronavirus vaccine in the US
* Deliberations on the vaccine began among the panel of 23 scientists on Thursday
* They questioned how long the vaccine protected people against the virus
* Placebo trial participants will be able to opt out of the study to get the vaccine once it is approved
* But that presents the problem of not having anyone to compare the data to and knowing what the long term effects of the vaccine is
* They also commented on there was no information about if the vaccine is safe for pregnant women
* The US's slow timeline is outraging many, especially given that Pfizer is an American company
* Once approved, the federal government then has to distribute the vaccine to the states
* The first to get it will be nursing home staff and residents and healthcare workers
* The US had its deadliest day of the pandemic on Wednesday with 3,045 deaths
The US Food and Drug Administration (FDA) vaccine advisory panel has voted to give Pfizer's coronavirus vaccine emergency approval.
It's the last crucial decision before FDA authorizes the shot to be given to Americans, a historic step toward controlling the COVID-19 pandemic in the U.S., which set another grim record with more than 3,000 deaths recorded Wednesday.
Now, the FDA itself will have to accept the committee's recommendation and Commissioner Stephen Hahn will have to sign off on the emergency approval.
Read more ....
WNU Editor: Faster please.
More News On The FDA Endorsing The Widespread Use Of Pfizer COVID-19 Vaccine
US expert panel endorses Pfizer Covid-19 vaccine, in key step toward national distribution -- France 24 U.S. FDA advisers overwhelmingly back authorizing Pfizer COVID-19 vaccine -- Reuters
F.D.A. Panel Gives Green Light to Pfizer's Covid Vaccine -- New York Times
